Samsung hires top AI guru as head of R&D hub
by Maria Thomas
Updated Jun 24, 2020
Seung, 54, would lead Samsung Research, the R&D hub of Samsung's set business. He will be responsible for managing Samsung's 15 R&D centers and seven AI centres in 13 countries to secure future technologies, according to the company.
Samsung said it expects Seung, who previously worked at the Massachusetts Institute of Technology (MIT) and Bell Labs, to boost its AI capability in the era of the Fourth Industrial Revolution by utilizing his experience, research ability and network.
Since 2018, the Korean-American has been helping Samsung's research and business plans in the AI sector as chief research scientist at Samsung Research, contributing to the establishment of global AI centers and the recruitment of talented scientists.
Samsung, the world's largest memory chip and smartphone maker, said reinforcing its AI capability will also enhance its competitiveness in the non-memory semiconductor sector, reports Yonhap news agency.
In April last year, Samsung announced a vision to become the world's No. 1 logic chip maker by 2030 by investing 133 trillion won ($110 billion) and bolstering its competitiveness in the system LSI and foundry businesses.
Seung's appointment comes after Samsung Electronics Vice Chairman Lee Jae-yong, the de facto leader of South Korea's top conglomerate, vowed to bring in talented individuals who can make Samsung better during his press conference last month.
Related Articles
- Optical Illusion Brain Test: If you have Sharp Eyes Find the Number 442 in 20 Secs
- London-based firm Nothing to release its Phone (2)
- Covid will continue to cause mini-waves, not become seasonal yet: Scientists
- Hackers offering crypto accounts for as low as $30 on darknet
- Reddit's new feature to allow users to share its content on other platforms
- Surgical masks can help kids fight respiratory infections: Study
- LinkedIn's new AI feature to write messages to hiring team
- Microsoft introduces Xbox Game Pass' new Friend Referral programme
- Disbursed over Rs 31 cr in claims to delivery partners in FY22-23: Swiggy
- India emerging as favourable destination for clinical trials: Report